Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01348256
What this trial is testing

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07772557
What this trial is testing

Adjuvant Therapy for Potentially Immunotherapy-Responsive Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 108
Testing effectiveness (Phase 2)Looking for participantsNCT06056336
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy
Guo Xufeng 73
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486687
What this trial is testing

Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early SettingEarly Stage Triple-Negative Breast CarcinomaTriple -Negative Breast Cancer+2 more
The Netherlands Cancer Institute 1,000
Not applicableActive Not RecruitingNCT04990726
What this trial is testing

Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+5 more
M.D. Anderson Cancer Center 126
Testing effectiveness (Phase 2)Study completedNCT03406650
What this trial is testing

Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer.

Who this might be right for
Urothelial Cancer
Swiss Cancer Institute 61
Large-scale testing (Phase 3)UnknownNCT02415699
What this trial is testing

DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Early research (Phase 1)Active Not RecruitingNCT04323046
What this trial is testing

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioblastoma+3 more
Sabine Mueller, MD, PhD 9
Testing effectiveness (Phase 2)Looking for participantsNCT06965231
What this trial is testing

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

Who this might be right for
Melanoma of SkinAcral MelanomaStage II Melanoma
Fudan University 58
Not applicableLooking for participantsNCT06598761
What this trial is testing

Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC

Who this might be right for
Ureter CancerRenal Pelvic CarcinomaAdvanced Urothelial Carcinoma
Peking University First Hospital 60
Early research (Phase 1)Study completedNCT00437502
What this trial is testing

A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer

Who this might be right for
Epithelial Ovarian, Tubal or Peritoneal Cancer
Michael Morse, MD 8
Large-scale testing (Phase 3)UnknownNCT05213312
What this trial is testing

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 90
Testing effectiveness (Phase 2)UnknownNCT04981665
What this trial is testing

Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Who this might be right for
Hepatocellular CarcinomaAdjuvant Therapy
Zhejiang University 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07132528
What this trial is testing

Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07561775
What this trial is testing

Adebrelimab Plus S-1 for Resected Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaBiliary Tract Cancer
Xingjun Guo 40
Very early researchWithdrawnNCT03574220
What this trial is testing

Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03844750
What this trial is testing

Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+2 more
Chloe Atreya, MD, PhD 6
Testing effectiveness (Phase 2)UnknownNCT06566391
What this trial is testing

Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma

Who this might be right for
Melanoma
European Institute of Oncology 35
Testing effectiveness (Phase 2)UnknownNCT02429440
What this trial is testing

Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides

Who this might be right for
Renal Cell CancerAdvanced Renal Cell Cancer
University Hospital Tuebingen 40
Testing effectiveness (Phase 2)Study completedNCT04911621
What this trial is testing

Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine Glioma
University Hospital, Antwerp 10
Next Page